ISAM AWARDS 2007
Awarded at the 16th International Congress, Tours, France

Career Achievement Award

Dr. Gerald Smaldone is a Professor of Medicine, Physiology and Biophysics at the State University of New York at Stony Brook. He received a Bachelors Degree in Chemical Engineering at New York University School of Engineering in 1969. In 1975, he completed a combined M.D., Ph.D. Program under the tutelage of Edward H. Bergofsky, M.D. at New York University School of Medicine. His thesis was in pulmonary mechanics. Dr. Smaldone received his clinical training as an intern and resident in the medicine program at The University of Rochester, New York, Strong Memorial Hospital. Between 1977 and 1980 he completed fellowships in Pulmonary Medicine and Environmental Physiology at The Johns Hopkins University. Since 1980, he has been at Stony Brook as a member of the Pulmonary/Critical Care Division, Department of Medicine. In 1996 he became Division Head. His research activities include a long-standing interest in pulmonary mechanics, the use of aerosols as special tools to study respiratory behavior and the development of better techniques for aerosolized drug delivery. Presently, he is actively involved in multiple projects utilizing monodisperse and polydisperse aerosols directed towards the study of inflammatory airway disease, airway geometry and drug delivery. In addition to his research activities, Dr. Smaldone actively practices at University Hospital. He specializes in pulmonary and critical care medicine. He is also the founding editor of the Journal of Aerosol Medicine.

Thomas T. Mercer Award (jointly sponsored with AAAR)

Steve Newman is currently a Scientific Consultant based in Nottingham, UK. He holds a BA in Physics from the University of Oxford. In 1971 he joined the Department of Medical Physics at the Royal Free Hospital and School of Medicine, London, and from 1977 began research into inhaled drug delivery, leading to a PhD from the Faculty of Medicine in the University of London in 1982. He subsequently became a full-time member of the Department of Thoracic Medicine at the Royal Free Hospital and School of Medicine, where he developed his interest in pulmonary and nasal drug delivery for both local and systemic applications, with emphasis on inhaler devices and their assessment by in vitro and in vivo techniques. From 1991 to 2004, Steve was a Director of Pharmaceutical Profiles, a company based in Nottingham, UK, that uses radionuclide imaging in vivo to assess delivery of pharmaceutical dosage forms. Steve is a Fellow of the Institute of Physics and Engineering in Medicine (FIPEM), and also a Fellow of the Institute of Physics (FinstP). He has published over 220 research papers, invited articles and book chapters. He has given numerous lectures, both at international conferences, and within the pharmaceutical and medical communities, and is a member of the editorial boards of several journals.

Young Investigator Award

Tim Corcoran is a Research Assistant Professor of Medicine at the University of Pittsburgh. He also holds secondary appointments in the Departments of Bioengineering and Chemical Engineering at the University of Pittsburgh, and in Biomedical Engineering at Carnegie Mellon University. He received his B.S. and M.S. degrees in Mechanical Engineering from Lehigh University in 1990 and 1992. He received a Ph.D. in Biomedical Engineering from Carnegie Mellon University in 2000. His past research interests have included the development of inhaled medications for lung transplant recipients and patients with cystic fibrosis. This work has included in vitro studies of aerosol drug delivery systems, the performance of radioscintigraphy deposition studies, and the development of adjuncts to improve drug delivery. More recently he has become involved in the performance of mucociliary clearance studies and the development of new aerosol-based outcome measurements for use in clinical studies of cystic fibrosis.

Student Research Award

Antoine Minne received his PharmD from the Universite catholique de Louvain in 2003. He is completing his PhD in the group of Prof. Rita Vanbever at the division of Pharmaceutical Technology, School of Pharmacy, Universite catholique de Louvain, Belgium. The group is interested in the optimization of inhalation aerosols for systemic absorption of therapeutic proteins and peptides, as well as in the pulmonary delivery of vaccines as an alternative to injection. Antoine Minne worked on the development of an inhaled influenza vaccine. He showed that delivery of the vaccine to the deep lung induced the broadest and most intense immune response over other respiratory tract regions and i.m. injection. Moreover, pulmonary administration was safe as it did not induce significant acute or chronic lung inflammation in healthy animals and did not exacerbate the asthmatic condition of allergen-sensitized animals. The continuation of Antoine Minne’s PhD work involved the formulation of a spray-dried carrier powder with optimal physico-chemical and aerodynamic properties and the assessment of its deposition pattern within the respiratory tract of mice. Finally, he showed that the excipients used in the dry-powder formulation might adjuvant pulmonary influenza.

Juraj Ferin Award (for outstanding contributions to ISAM)

Wolfgang G. Kreyling is a biophysicist coordinating all aerosol-related research within the GSF Focus Network Aerosols and Health spanning R&D work over five GSF-institutes ranging from material sciences to toxicology and epidemiology. He is deputy director of the GSF-Institute for Inhalation Biology. His research interests range from aerosol sciences and nanoparticle technology to biophysics of the lungs reaching from the characterization of ambient aerosols to particle dosimetry and nanoparticle lung interactions on the level of the entire organism, cells like alveolar macrophages, and molecular compounds. Using his quantitative biokinetics rodent model he recently demonstrated that the biokinetics and accumulation of nanoparticles in secondary target organs like liver, kidneys, brain, heart and reproductive organs depends strongly on their properties such as size and surface ligands. He received his Ph.D. at the Technical University of Munich. In 1985/86 he spent a sabbatical at the Harvard School of Public Health in Boston, MA, USA. He holds more than 150 peer-reviewed publications in international journals and books. As early as 1983 he became interested in ISAM and served in several functions including a 12-years-service within the board of ISAM.

Best Oral Presentation

Michael Bur studied pharmacy at the Saarland University, Germany and graduated in 2003. His diploma thesis was about ion fluxes across tight cell monolayers of primary alveolar cells. Currently he is doing his PhD in the group of Prof. Claus-Michael Lehr at the department of biopharmacy and pharmaceutical technology, Saarland University. The topic of his research is cell compatible drug deposition and absorption models which mimic the aerosol properties as well as the situation on the human air-blood-barrier. Mainly human alveolar primary cells cultivated on an air interface are used as model of the human air blood barrier. Deposition of medical aerosols is conducted with size separating by a cell compatible multi stage liquid impinger or without size separation with the aid of an insufflator syringe. Influences of particles size, fluid volume on the cell monolayer, and wettability of the applied aerosol formulations are investigated. Michael Bur’s work is supported in parts by the Federal Ministry of Education and Research, Project: NanoInhale (13N8890).

ISAM AWARDS 2006

Thomas T. Mercer Award (jointly sponsored with AAAR)

Professor Myrna Dolovich has been at the forefront of aerosol research for the past 40 years. In her early years she worked with renowned pulmonary physiologists Drs Joseph Milic-Emili and David Bates to expand our understanding of regional ventilation in the normal and diseased lung using gamma scintigraphic methods. She later applied similar imaging techniques to establish the methodologies currently used by many of us for assessing distribution of inhaled aerosols in the lungs. On another front she worked closely with Drs Michael Newhouse and Ron Wolff to study mucociliary clearance from the lungs by scintigraphic methods. These early studies set the stage for current use of such methods to assess new therapeutic approaches for improving clearance of secretions from the lungs of cystic fibrosis and COPD patients. Such efficacy studies are now leading to new therapies that extend and improve the equality of life of CF patients. Most recently she has applied newer imaging methods, positron emission tomography (PET) to assess the sites of inflammation in patients as well as mapping deposition patterns of inhaled aerosols in 3D. Finally, Myrna has been a leader in developing and characterizing new aerosol delivery devices, especially metered dose inhalers and associated spacers, for use by adults and children with lung disease worldwide. She has led efforts to standardize the proper use of these devices to achieve efficient delivery of aerosolized drug to the lungs of patients, also working with the Standards Council of Canada and the International Standards Organization developing standards for drug delivery devices. These efforts make her especially worthy of the Mercer award for excellence in the field of medicinal aerosols. While working with some of the giants of pulmonary medicine, Myrna has established herself as a giant of aerosol medicine. In the process she has also influenced and trained many younger researcher sin the field, all of who can attest to her commitment and care towards advancing the field of medicinal aerosols. Myrna has published 137 book chapters and peer-reviewed papers in the medical literature and has spoken extensively on pulmonary drug delivery systems and imaging. She has served on the Board of Directors of the International Society for Aerosols in Medicine (ISAM) and is a member of the Editorial Boards of the Journal of Aerosols in Medicine and Pediatric Allergy, Asthma and Immunology. Myrna Dolovich currently continues her contributions to medical aerosol research as Associate Clinical Professor, Department of Medicine, Faculty of Health Sciences, McMaster University.

ISAM AWARDS 2005
Awarded at the 15th International Congress, Perth, Australia

Career Achievement Award

Michael Newhouse obtained his MD from Queen’s University, Kingston, ON, Canada in 1959. He graduated MSc in Experimental Medicine from McGill University/Royal Victoria Hospital and simultaneously completed his postgraduate studies in pulmonology/Cardiology in 1964. The same year he established a pulmonary function lab and clinical pulmonology service at St Joseph’s Hospital, Hamilton, Canada. In 1965 he started what eventually became the McMaster Medical Aerosol Research Laboratory where he and colleagues first introduced the use of the aerosol scintigraphy to study mucus clearance in Cystic Fibrosis, to evaluate the effect of air pollutants on normal volunteers and to determine lung aerosol drug dose and distribution. He studied mucus clearance on the effect of a number of physical and physiological variables in CF. Perhaps the most important contribution of his aerosol lab to pulmonary medicine was the development, in the early 1980s, with several colleagues of the AeroChamber, an aerosol holding chamber that greatly improved the reliability of aerosol delivery from pMDIs. He has published about 150 peer-reviewed articles, has been co-editor of professional and lay books, has been a member of the editorial board of several journals, and has been author or co-author of numerous book chapters.

Thomas T. Mercer Award (jointly sponsored with AAAR)

Andy Clark is currently Chief Technical Officer for Nektar Therapeutics, San Carlos, CA. Prior to joining Nektar (formerly Inhale Therapeutic Systems) in 1996 Dr. Clark led a pulmonary protein delivery group at Genentech, Inc. where he worked on rhDNAse and pulmonary delivery of antibodies. From 1980 to 1991, he was the section head of Respiratory Physics for Fisons plc, where he led a team dedicated to developing a fundamental understanding of pharmaceutical aerosols and trheir application to asthma medications. He holds a B.Sc. in applied physics from DeMontfort University, Leicester, England, and a Ph.D. in aerosol science from Loughborough University of Technology, Loughborough, England. In 1997 Dr. Clark was the first recipient of the International Society for Aerosols in Medicine (ISAM) young investigator award for outstanding contributions to aerosol science and he was president of ISAM from 2001 to 2003. He has authored over 40 papers on aspects of formulation and delivery of pharmaceutical aerosols and contributed a number of book chapters.

Young Investigator Award

Dr Sunalene Devadason heads the Paediatric Aerosol laboratory in the UWA School of Paediatrics and has been involved in this field of research since 1993. The primary focus of her research is the optimisation of aerosol therapy for respiratory disease in children, investigating both the in vitro efficiency of devices and drug formulations, and the mechanics of in vivo delivery to children of different ages. In recent years, this research has included the development of different strategies to improve adherence to therapy in adolescents with severe asthma, and the use of incentive devices for asthma therapy in young children. Additionally, she has recently become involved in studies investigating the toxic effects of aerosolised emissions from cigarette smoke. Her research is supported by both peer-reviewed competitive grants (including a bioengineering grant from the NIH) and industry-funded projects. Since 1995, she has co-authored 30 articles in peer-reviewed journals, and one book chapter, with five further articles currently submitted for publication. Dr Devadason was an active member of the organising committee for the 2005 biennial ISAM Congress held in Perth, Australia, and was responsible for building and maintaining the conference website and for raising sponsorship funding for the Congress.

Student Research Award

Fabian Blank received his M.S. in biology with major in zoology from the University of Bern in 2003. He is doing his PhD in the group of Prof. Peter Gehr at the division of Histology, Institute of Anatomy, University of Bern, Switzerland. The group is interested in particle-cell interactions in the lung with respect to the functions of barrier components which prevent inhaled foreign particulate matter from gaining access to the organism. Supervised by Dr. Barbara Rothen-Rutishauser Fabian Blank works with a triple cell co-culture which simulates the respiratory tract wall. This system consists of alveolar epithelial cells, macrophages and dendritic cells which are grown in a two chamber system separated by a microporous membrane. After the cells are exposed to air, particles are applied to the co-cultures and particle-cell interactions are examined with confocal laser scanning microscopy and transmission electron microscopy. Furthermore this system is used to study interactions of deposited particles with surfactant, which is produced by the air-exposed epithelial cells. Fabian Blank’s Work is supported by the Swiss National Science Foundation, the Novartis Foundation and the Swiss Agency for the Environment, Forests and Landscape.

Juraj Ferin Award (for outstanding contributions to ISAM)

Peter Gehr is Professor and Chairman of the Department of Anatomy, University of Bern, Switzerland. He has received his PhD 1974 at the University of Bern where he became an Assistant Professor in 1975, an Associate Professor in 1983 and a full professor in 1988. In 1977 he was a visiting lecturer at the University of Nairobi, Kenya and from 1980 to 1982 he was a visiting Assistant Professor at the Harvard School of Public Health, Boston USA. He was first studying the structure-function correlation of the gas exchange structures of the lungs. Later he became interested in the mechanisms of particle-lung interactions. He focused his work on the interaction of particles with the surfactant, and later with the surface of cells. It is through this work he met members of ISAM and developed great interest in the activities of this Society. Most recent studies deal with the interaction of nanoparticles with cells. A further interest of his is the interrelationship of different cells which are exposed to particles.

Thomas T. Mercer Award (jointly sponsored with AAAR)

Igor Gonda has been passionately interested in the development of therapeutic inhalations that can help patients to improve their quality of life. With his students and colleagues, he conducted research including formulation and lung delivery of small molecules, peptides, proteins and genes, SPECT imaging of radioaerosols to investigate deposition and mucociliary clearance, hygroscopic growth of aerosols and its control, and engineering of solid particles to optimize their deposition and disposition in the respiratory tract. His work on theoretical models of suspension aerosols, deposition of inhaled particles, and disposition of materials from the nose and the respiratory tract was carried out to improve the way in which drugs are delivered through the lung and nose. Igor held several responsibilities in ISAM and AAAR and was in advisory role for the Journal of Aerosol Medicine and Aerosol Science and Technology and is currently on editorial boards of a number of pharmaceutical journals. Igor was involved in the development of a meaningful global regulatory framework for therapeutic inhalations. He is the Chief Executive Officer of Acrux Limited (Australia), a pharmaceutical company with transdermal drug delivery sprays, and the Chairman of the Scientific Advisory Board, Aradigm Corporation (USA), a drug delivery company developing inhalation and needleless injector products.

Career Achievement Award

Peter Gehr is Professor of Anatomy at the Department of Anatomy, University of Bern, Switzerland. He received his PhD in 1974 from the University of Bern where he became an Assistant Professor in 1975, an Associate Professor in 1983 and a full professor in 1988. In 1977 he was a visiting lecturer at the University of Nairobi, Kenya and from 1980 to 1982 he was a visiting Assistant Professor at the Harvard School of Public Health, Boston USA. He was first in studying structure-function correlations of the gas exchange apparatus of the lung. Later he became interested in the mechanisms of particle-lung interactions. He focused his work on the interaction of particles with surfactant, and later with surface of cells. It is through this work he met members of ISAM and developed great interest in the activities of the Society. From 1997 to 1999 he served as ISAM president and in 2001 he was congress president.

Thomas T. Mercer Award (jointly sponsored with AAAR)

Günter Oberdörster is Professor in the Department of Environmental Medicine and Head of the Division of Respiratory Biology & Toxicology at the University of Rochester and Director of the University of Rochester Ultrafine Particle Center. His studies with ultrafine particles have influenced the field of inhalation toxicology, raising awareness of their unique toxicological potential. Dr. Oberdörster earned his D.V.M. and Ph.D. (Pharmacology) from the University of Giessen in Germany. He has served on national and international committees, among others NIEHS study sections, EPA’s Science Advisory Board committees, Board of Scientific Counselors of the National Toxicology Program, NRC’s Committee on Toxicology, TLV Committee of the American Conference of Governmental Industrial Hygienists, several working groups of IARC, WHO consultancies to the governments of Kuwait, Iraq and South Korea, IUPAC Commission on Toxicology, ad hoc Expert Group on Chemicals Bureau of the European Commission, and advisory panel of the German Research Association, and continues to serve on EPA’s CASAC and on NRC’s Committee on Research Priorities for Airborne Particulate Matter. Dr. Oberdörster is a past-president of the Society of Toxicology’s Inhalation Toxicology Specialty Section (ISS) and has been a Board Member of ISAM (1988-1999). He is a recipient of the Joseph von Fraunhofer Prize (Germany), the Society of Toxicology’s ISS Career Achievement Award, and the Society of Toxicology’s ISS 1997 Paper of the Year Award. He is on the editorial boards of the Journal of Aerosol Medicine, International J. Hygiene & Environmental Health, and Associate Editor of Inhalation

Young Investigator Award

James S. Brown is a Research Associate at the Center for Environmental Medicine, Asthma, and Lung Biology in the University of North Carolina School of Medicine, Chapel Hill, NC. He received a B.S. from Temple University, Philadelphia, PA, 1989; a M.S. in Public Health from the University of North Carolina, Chapel Hill, NC, 1991; and a Ph.D. in Environmental Science and Engineering from the University of North Carolina, Chapel Hill, NC, 2000. His research on particle dispersion, deposition, and clearance in the human lung has resulted in numerous publications and presentations. Several of his studies have investigated the effect of ventilation distribution on particle behavior in patients with obstructive lung diseases. These studies have significant implications for particle dosimetry because they are relevant to both regional tissue doses from exposure to ambient particulate matter as well as the delivery of therapeutic aerosols in the diseased lung. Using physiological parameters and regional ventilation data from his experimental studies, he has recently developed and validated a mathematical model describing the regional deposition of inhaled aerosols in cystic fibrosis patients.

Student Research Award

Michelle Dawson received a B.S. in Biomedical Engineering from Louisiana Tech University in 1999. Opting to continue her education in a more traditional engineering discipline, while having the opportunity to do biomedical research, Michelle elected to work toward her Ph.D. in Chemical and Biomolecular Engineering at the Johns Hopkins University with Dr. Justin Hanes. The major areas of research within the Hanes group are pulmonary drug delivery, non-viral gene delivery, and the synthesis of new biopolymers for advanced medical applicaitons. Michelle’s research focuses on the optimization of drug and gene carriers for aerosol delivery in the treatment of cystic fibrosis and other diseases that affect the lung. Using epifluoresent and confocal microscopy, combined with high resolution real-time multiple nanoparticle tracking, Michelle has focused on quantifying and optimizing particle transport rates in mucus from CF patients, which is an extracellular barrier to aerosolized drug and gene carrier transport. She has also been able to study the microrheology of mucus quantitatively through the use of multiple nanoparticle tracking of the microscopic displacements of small monodisperse particles in CF mucus as a function of time. Michelle has received numerous awards, including fellowships from the NSF, the Ford Foundation, and ARCS

Juraj Ferin Award (for outstanding contributions to ISAM)

Gerald Smaldone is a Professor of Medicine, Physiology and Biophysics at the State University of New York at Stony Brook. He received a Bachelors Degree in Chemical Engineering from the New York University School of Engineering in 1969. In 1975, he completed a combined M.D., Ph.D. Program under the tutelage of Edward H. Bergofsky, M.D. at New York University School of Medicine. His thesis was in pulmonary mechanics. Dr. Smaldone received his clinical training as an intern and resident in the medicine program at The University of Rochester, New York, Strong Memorial Hospital. Between 1977 and 1980 he completed fellowships in Pulmonary Medicine and Environmental Physiology at The Johns Hopkins University. Since 1980, he has been at Stony Brook as a member of the Pulmonary/Critical Care Division, Department of Medicine. In 1996 he became Division Head. His research activities include a long-standing interest in pulmonary mechanics, the use of aerosols as special tools to study respiratory behaviour and the development of better techniques for aerosolised drug delivery. Presently, he is actively involved in multiple projects utilizing monodisperse and polydisperse aerosols directed towards the study of inflammatory airway disease, airway geometry and drug delivery. In addition to his research activities, Dr. Smaldone actively practices at University Hospital. He specializes in pulmonary and critical care medicine. He is also the founding editor of the Journal of Aerosol Medicine.

ISAM AWARDS 2002

THOMAS T MERCER AWARD

Ronal K. Wolff is currently leader of the Inhalation Toxicology group at Lilly Research Laboratories, a division of Eli Lilly and Company in Greenfield, Indiana. He has a Ph.D. in Medical Biophysics from the University of Toronto, Canada (1972). Dr. Wolff was a postdoctoral fellow at McMaster University, Canada studying deposition and clearance of inhaled aerosols in human subjects (1973-76). He was a staff scientist at the Lovelace Inhalation Toxicology Research Institute, in Albuquerque, New Mexico from 1976 to 1988 studying the effects of a range of inhaled agents on lung defense mechanisms in a wide variety of animal models. His work showing that high concentrations of diesel exhaust inhibited lung clearance of particles leading to particle overload was an important part of the overall risk assessment of diesel exhaust. Since joining Lilly Research Laboratories in 1988 Dr. Wolff has been at the forefront of investigating the use of respiratory tract delivery of proteins for therapeutic use with an emphasis on using large animal models for pharmacologic and toxicologic evaluations. His group provided definitive data in large animals showing that pulmonary delivery of proteins is a viable clinical approach. He also spearheaded efforts at American Association for Aerosol Research (AAAR) to bring the area of pharmaceutical aerosols into greater prominence by co-organizing symposia. He has published over 100 articles in the fields of inhalation toxicology and inhaled protein delivery and has lectured at meetings throughout the world. He is a Diplomate of the American Board of Toxicology, and a member of the editorial boards of Aerosol Science and Technology, and the Journal of Aerosol Medicine. He has also been a member of the Board of Directors of the International Society of Aerosols in Medicine and AAAR, and is a Past-President of AAAR.

ISAM AWARDS 2001
Awarded at the 13th International Congress, Interlaken, Switzerland

CAREER ACHIEVEMENT AWARD

Joachim Heyder is director of the Institute for Inhalation Biology at the GSF-National Research Center for Environment and Health at Neuherberg/Munich, Germany. He received a master´s degree in physics in 1965, a doctorate degree in 1968 and the venia legendi for biophysics in 1976 from the Goethe-University at Frankfurt am Main. In 1965, he joined the Max Planck-Institute for Biophysics at Frankfurt, Germany. Following postdoctoral training in C.N. Davies´ aerosol laboratory at the London School of Hygiene and Tropical Medicine, Dr. Heyder initiated a program on biomedical aerosol research at the GSF-Institute for Biophysical Radiation Research at Frankfurt which became part of an international effort to understand aerosol particle behaviour in the respiratory system. As a result of this activity the School of Medicine and Dentistry of Rochester University invited him in 1972 to work at P.E. Morrow´s aerosol laboratory. In 1984 he received an invitation from the Harvard School of Public Health to work as a visiting associate professor at J.D. Brain´s Respiratory Biology Program. Since 1986 Dr. Heyder works at the main campus of the GSF-National Research Center for Environment and Health at Neuherberg/Munich. Dr. Heyder has made major contributions to biomedical aerosol science in numerous peer-reviewed articles published in all major journals in this field. His current interest focuses on responses of the respiratory defence system to inhaled ambient particles (inhalation toxicology) and on targeting and dosimetry of inhaled pharmaceutical particles (inhalation therapy).

THOMAS T MERCER AWARD (jointly sponsored with AAAR)

C. Arden Pope III is a professor of economics at Brigham Young University.  He has a Ph.D. from Iowa State University (1981) where he studied economics and statistics.  He has had appointments at Iowa State and Texas A&M Universities and has been an IPH Fellow in Environmental Health and Public Policy at the Harvard University School of Public Health.  He has conducted research dealing with a wide range of natural resource and environmental issues, but the bulk of his research over the last 15 years has focused on epidemiological studies evaluating health effects of particulate air pollution.  He has conducted many of the key, pioneering epidemiological analyses of both short-term and long-term effects of particulate air pollution.  He has also played a prominent role in reviewing and interpreting this rapidly growing literature.  Professor Pope has worked closely with various other excellent scientists and readily acknowledges their indispensable collaborative contributions.

YOUNG INVESTIGATOR AWARD

Professor Warren H. Finlay is the founding Director of the Aerosol Research Laboratory of Alberta (ARLA). After receiving his Ph.D. from Stanford University in 1987, he joined the University of Alberta as an Assistant Professor, and was promoted to the rank of Professor in 1993. His research activities in modeling, deposition, characterization and formulation of inhaled aerosols for respiratory delivery have led to numerous journal publications, in addition to many collaborations with the pharmaceutical industry. He is the author of a recently published book entitled The Mechanics of Inhaled Pharmaceutical Aerosols: An Introduction (Academic Press).  He has also published in more traditional engineering fields, and has taught widely at the University of Alberta at both the undergraduate and graduate levels in Mechanical Engineering, Biomedical Engineering and Pharmacy. He is the recipient of various previous academic awards for outstanding achievement, including a McCalla Research Professorship and the Birks Gold Medal in Engineering, among others.

STUDENT RESEARCH AWARD

Julie Suman received her B.S. in Pharmacy from Duquesne University, graduating Magna Cum Laude in 1996.  She is currently a Ph.D. candidate in the School of Pharmacy, Department of Pharmaceutical Sciences at the University of Maryland.  Julie’s doctoral research involves intranasal delivery of aerosols in humans, and the relationship between in vitro aerosol characteristics and in vivo deposition pattern.  Her work is published in three peer-reviewed articles and has been presented during podium sessions at three national meetings.  Her other awards include a Phi Lambda Sigma-Glaxo Wellcome-American Foundation for Pharmaceutical Education (AFPE) First Year Graduate Scholarship (1996), AFPE Pre-doctoral Fellowships for the years 1998, 1999 and 2000 and USP Fellowships for the years 1999-2000 and 2000-2001.  Julie’s advisors are Richard N. Dalby, Ph.D., Associate Professor University of Maryland School of Pharmacy and Beth L. Laube, Ph.D., Associate Professor Johns Hopkins School of Medicine. Following the completion of Julie’s thesis, she will begin work at the company she founded, Next Breath, LLC.

JURAI FERIN AWARD  (for outstanding contributions to ISAM)

Helger Hauck (born 1942 in Melk, Austria) received his PhD from the University in Vienna in Physics and Mathematics. He served as assistant professor at the institute for medical physics at the University of Vienna. In 1991 he spent a year as PHS-fellow in Rochester NY. He received the Erich Schmid Award from the Austrian Academy of Sciences and the Hygiene award from the Austrian Society for Hygiene and Microbiology. In 1979 he became Dozent for Medical Physics and in 1990 professor at the institute for environmental hygiene of the University of Vienna. As chairman of the Clean Air Committee of the Austrian Standards Institute he is also involved in the European Standardization Process (CEN). In 1992 he was appointed as vice chairman of the Clean Air Commission of the Austrian Academy of Sciences. His research activities started in aerosol physics and measurement where he published one of the first particle size spectrum of an MDI. Later he became interested in carbon monoxide toxicology and developed a model of CO-uptake. As a governmental adviser on air pollution issues he did some statistical investigations on pollution data and their relation to environmental standards. At present he is organizing a big particles and health effects research project in Austria. His involvement in ISAM started in 1975, when he organized the first ISAM Congress in Baden/Vienna in Austria. Later on he managed, with K. Albegger and W. Hofmann, the ISAM sponsored Austrian colloquia on deposition and clearance in Graz, Bad Gleichenberg, Salzburg and Vienna. In 1987, when ISAM was reorganized and promoted as international society in the West, he started his activity as ISAM treasurer. As an academic teacher he is still teaching at the medical school of the University of Vienna medical physics and environmental hygiene.